These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 3108134

  • 1. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration.
    Coiro V, Butturini U, Gnudi A, Volpi R, d'Amato L, Speroni G, Capretti L, Roti E, Chiodera P.
    Horm Res; 1987; 25(4):206-14. PubMed ID: 3108134
    [Abstract] [Full Text] [Related]

  • 2. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
    Marcondes JA, Santomauro AT, Minanni SL, Wajchenberg BL.
    Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
    [Abstract] [Full Text] [Related]

  • 3. On the role of dopamine receptors in the central regulation of human TSH.
    Delitala G, Devilla L, Canessa A, D'Asta F.
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thyrotropin alpha- and beta-subunit responses to thyrotropin-releasing hormone and domperidone in normal subjects and in patients with microprolactinomas.
    Persani L, Beck-Peccoz P, Medri G, Conti A, Faglia G.
    Neuroendocrinology; 1991 Apr; 53(4):411-5. PubMed ID: 1710792
    [Abstract] [Full Text] [Related]

  • 10. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
    Valensi P, Combes ME, Perret G, Attali JR.
    J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
    [Abstract] [Full Text] [Related]

  • 11. Increased plasma prolactin levels in ovariectomized thyroidectomized rats treated with estrogen.
    Pan JT, Chen CW.
    Endocrinology; 1990 Jun; 126(6):3146-52. PubMed ID: 1972060
    [Abstract] [Full Text] [Related]

  • 12. Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia.
    Ghigo E, Pogliano G, Campagnoli C, Bertagna A, Camanni F, Massara F.
    J Endocrinol Invest; 1984 Oct; 7(5):525-7. PubMed ID: 6439773
    [Abstract] [Full Text] [Related]

  • 13. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM, Haas M, Trestian S, Zylber-Haran E, Shilo S.
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [Abstract] [Full Text] [Related]

  • 14. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
    Giammartino C, Ambrosi F, Pelicci G, Pagliacci MC, Fedeli L, Nicoletti I.
    Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
    [Abstract] [Full Text] [Related]

  • 15. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF, Rodriguez-Arnao MD, McGregor AM, Weightman D, Lewis M, Cook DB, Gomez-Pan A, Hall R.
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic control of TSH secretion in endogenous depression.
    Marchesi C, Chiodera P, De Risio C, Dassò L, Govi AM, De Ferri A, Piagneri B, Minelli R, Bianconi L, Gnudi A.
    Psychiatry Res; 1988 Sep; 25(3):277-82. PubMed ID: 3141942
    [Abstract] [Full Text] [Related]

  • 17. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E, Ciccarelli E, Novelli A, Massobrio M, Müller EE, Camanni F.
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH, Sobieszczyk S, Ain KB, Refetoff S.
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.